The addition of 177Lu-PSMA-617 to enzalutamide significantly improved overall survival and QOL in patients with metastatic ...

A new research paper was published in Aging (Aging-US) on January 3, 2025, in Volume 17, Issue 1, titled “Characterization of ...

The following is a summary of “Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population ...

The following is a summary of “Rescue Sedation after 5 mg or 10 mg of Droperidol as the Initial Treatment for Acute Agitation in the Emergency Department,” published in the January 2025 issue of ...

At 3 months, the median reduction in free factor XI levels with abelacimab at a dose of 150 mg was 99% (interquartile range, 98 to 99) and with abelacimab at a dose of 90 mg was 97% (interquartile ...

Based on our research, we estimate that the global investigative site community spent $170 million in 2024 to complete ...

This valuable study presents a mouse gastruloid model that can be used to generate hematopoietic progenitors as well as leukemic cells. However, in its current form, the manuscript is inadequate ...

Achieving obesity remission reduced children’s and teens’ risk for developing type 2 diabetes, hypertension and dyslipidemia ...

Stigma-related behaviors, attitudes, knowledge, and general stigma were the primary outcomes. Empowerment and self-efficacy were secondary outcomes.

Children diagnosed with interstitial lung disease often survive into adulthood, when they are likely to need care for related impairments.

EULAR/ACR SLE classification criteria were not linked to mortality or hospitalization, a developed ominosity model adequately predicted mortality.

1. Re-evaluation of Safe Harbour Regulations (SHR): Taxpayers expect CBDT to relook at safe-harbour rates, remove the barrier of turnover threshold to expand coverage, and extend the safe harbour ...